tiprankstipranks
Aptevo Therapeutics Inc (DE:AP8N)
FRANKFURT:AP8N

Aptevo Therapeutics (AP8N) Stock Investors

0 Followers
Based on 718,776 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DE:AP8N
On average, investors allocate 0.00% of their portfolios to DE:AP8N
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 718,776 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding AP8N

3.8%
Last 7
Days
4.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DE:AP8N, out of 718,776 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

AP8N Investor Activity

No data currently available
Based on the activity of 13,441 investors who made their portfolios public
The table shows changes in AP8N in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

AP8N Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.30%
-0.27%
+5.89%
38.89B
Consumer Cyclical
Merck & Company
4.07%
+0.56%
+3.72%
314.17B
Healthcare
Marathon Digital Holdings
6.02%
+3.91%
+9.19%
6.88B
Financial
Micron
5.39%
+2.21%
+7.99%
105.72B
Technology
Assertio Therapeutics
2.64%
-1.09%
-4.29%
83.54M
Healthcare
Blink Charging Co
5.01%
-0.14%
+4.17%
204.92M
Industrials
AMC Entertainment
5.39%
-0.39%
-2.60%
1.14B
Communication Services
Riot Platforms
5.16%
+1.07%
+4.79%
3.42B
Financial
Coherus Biosciences
2.59%
-1.07%
-4.11%
252.80M
Healthcare
Marvell
4.95%
+0.94%
+4.11%
68.60B
Technology
Based on the activity of 718,776 active portfolios
Open your Smart Portfolio

AP8N Investor Analysis

DE:AP8N investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
14.6%
of DE:AP8N holders
are under 35
Average Segment Performance
Average P/E Ratio43.88
Beta7.32
Dividend Yield5.62%
DE:AP8N investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
37.5%
of DE:AP8N holders
are between 35–55
Average Segment Performance
Average P/E Ratio47.96
Beta11.09
Dividend Yield6.73%
DE:AP8N investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
47.9%
of DE:AP8N holders
are over 55
Average Segment Performance
Average P/E Ratio35.58
Beta5.76
Dividend Yield5.55%
Overview of age group and performance of DE:AP8N stock investors
See who invests in AP8N according to age group and performance.

FAQ

How many retail Investors hold DE:AP8N?
<0.1% of TipRanks' retail investors hold DE:AP8N in their portfolios.
    What is DE:AP8N Investor Sentiment?
    DE:AP8N’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of DE:AP8N in the last 7 days?
      ▲ 3.8% of TipRanks' retail investors changed their holding of DE:AP8N in the last 7 days.
        What percentage of retail investors changed their holding of DE:AP8N in the last 30 days?
        ▼ 4.4% of TipRanks' retail investors changed their holding of DE:AP8N in the last 30 days.
          What is the average age of retail investors who hold DE:AP8N?
          The average age of DE:AP8N Holders is over 55.
            What other stocks have DE:AP8N investors also bought?
            DE:AP8N Investors also bought DKNG, MRK, MARA, MU, ASRT, BLNK, AMC, RIOT, CHRS, MRVL.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Labs
              ATECAlphatec Holdings
              CORCencora
              BDXBecton Dickinson
              CAHCardinal Health
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis